The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie
Journal of Alzheimer's Disease, ISSN: 1875-8908, Vol: 55, Issue: 4, Page: 1659-1666
2017
- 17Citations
- 40Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- 17
- CrossRef16
- Captures40
- Readers40
- 40
- Mentions1
- News Mentions1
- News1
Most Recent News
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.
J Alzheimers Dis. 2016 Nov 28; Authors: Sancesario GM, Toniolo S, Chiasserini D, Di Santo SG, Zegeer J, Bernardi G, for SIBioC-Study Group of Clinical Biochemistry of Biological Fluids other than Blood, Musicco M, for SINdem-ITALPLANED, Caltagirone C, Parnetti L, Bernardini S PubMed: 27911328 Submit Comment
Article Description
Although the use of cerebrospinal fluid (CSF) amyloid β (Aβ), tau (T-tau), and phosphorylated tau (p-tau) gives added diagnostic and prognostic values, the diffusion is still limited in clinical practice and only a restricted number of patients receive an integrated clinico-biological diagnosis. By a survey, we aimed to do a "selfie" of the use and diffusion of CSF biomarkers of dementia in Italy, the standardization of pre-analytical procedures, the harmonization of ranges, and the participation to Quality Control programs. An online questionnaire was sent to the members of SIBioC and SINdem-ITALPLANED and to main neurological clinics all over Italy. In Italy, 25 laboratories provide biomarkers analysis in addition to a network of 15 neighboring hospitals. In sum, 40 neurological centers require CSF analyses. 7/20 regions (35) lack CSF laboratories. Standardization of pre-analytical procedures is present in 62.02 of the laboratories; only 56.00 of the laboratories participate in International Quality Control. There is no harmonization of cut-offs. In Italy, the use of CSF biomarkers is still limited in clinical practice. Standardization and harmonization of normal ranges are needed. To optimize and expand the use of CSF biomarkers, a cost-benefit analysis should be promoted by scientific societies and national health services.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85007271668&origin=inward; http://dx.doi.org/10.3233/jad-160975; http://www.ncbi.nlm.nih.gov/pubmed/27911328; http://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/JAD-160975; https://journals.sagepub.com/doi/full/10.3233/JAD-160975; https://dx.doi.org/10.3233/jad-160975; https://content.iospress.com:443/articles/journal-of-alzheimers-disease/jad160975
IOS Press
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know